Cure Pharmaceutical: Funding, Investors & Team (Oct 2026)
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin films on the market today. CURE is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and Germany, among other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.
Cure Pharmaceutical has raised $630k across 1 funding round on record, the most recent a Debt Financing of $630k announced in Sep 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cure Pharmaceutical Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Cure Pharmaceutical Funding Rounds
Cure Pharmaceutical Founders and Leadership Team
No contact details are on record for this team yet.
Cure Pharmaceutical Funding Compared to Other Biotechnology Startups
Cure Pharmaceutical's latest round of $630k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cure Pharmaceutical in Biotechnology and Oxnard
Companies Similar to Cure Pharmaceutical
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Cure Pharmaceutical Funding FAQs
What does Cure Pharmaceutical do?
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin films on the market today. CURE is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and Germany, among other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.
How much funding has Cure Pharmaceutical raised?
Cure Pharmaceutical has raised $630k across 1 round on record. The most recent is a Debt Financing of $630k announced in Sep 2022.
When did Cure Pharmaceutical last raise funding?
Cure Pharmaceutical's most recent funding round on record is a Debt Financing of $630k, announced in Sep 2022.
Who is the CEO of Cure Pharmaceutical?
Isaac Kwabena Adjei is listed as CEO at Cure Pharmaceutical.
Where is Cure Pharmaceutical headquartered?
Cure Pharmaceutical is based in Oxnard, California, United States.
How many employees does Cure Pharmaceutical have?
Cure Pharmaceutical is in the 51-100 employee band.
How does Cure Pharmaceutical's funding compare to other Biotechnology startups?
Cure Pharmaceutical's latest round of $630k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cure Pharmaceutical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cure Pharmaceutical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.